St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are recruiting adult participants for a phase 3 COVID-19 vaccine clinical trial. More information about the trial, including participant eligibility requirements, is available here. The two are partnering to offer a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ENSEMBLE trial, to evaluate the safety and efficacy of the Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S.
- November 13: Commercial Appeal
- November 13: Daily Memphian
- November 13: Local Memphis
- November 13: KAIT 8
- November 13: Memphis Flyer
- November 13: Memphis Business Journal
- November 13: One News Page
- November 13: WREG
- November 13: WREG News Channel 3 at 5:00
- November 13: WMC-TV
- November 13: FOX 16 News at 5:00PM